GILEAD 4331 300 (Viread 300 mg)
Generic Name: tenofovir
Pill imprint GILEAD 4331 300 has been identified as Viread 300 mg.
Viread is used in the treatment of hepatitis b; nonoccupational exposure; hiv infection and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Viread 300 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for GILEAD 4331 300
- Generic Name:
- 300 mg
- 17.00 mm
- Elliptical / Oval
- Prescription only
- Drug Class:
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Gilead Sciences
- National Drug Code (NDC):
- Inactive Ingredients:
- corn starch
FD&C Blue No. 2
hypromellose 2910 (15000 mPa.s)
|NDC Code||Manufacturer / Repackager|
|54569-5334||A S Medication Solutions LLC (repackager)|
|54868-4669||Physicians Total Care Inc (repackager)|
|68258-9003||Dispensing Solutions Inc. (repackager)|
|35356-0073||Lake Erie Medical and Surgical Supply (repackager)|
Note: Inactive ingredients may vary.
More about Viread (tenofovir)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.